Recruiting nowN/AAges 18 Years and up
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
Sponsor: Ohio State University Comprehensive Cancer Center · NCT06500065 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcoma
What it tests
- Computed Tomographyprocedure
- Gallium Ga 68-HA-DOTA-TATEradiation
- Positron Emission Tomographyprocedure
Where it's running1 site
- Recruiting now
Ohio State University Comprehensive Cancer Center
Columbus, Ohio 43210
- Gabriel R. Tinoco Suarez(contact)614-293-0109[email protected]
- Gabriel R. Tinoco Suarez(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Patients \>= 18 years of age * Patients diagnosed with any stage of soft tissue sarcomas candidates for systemic therapies * Patients with one standard of care PET/CT scan up to 30 days before enrollment at the Ohio State University facilities. Exclusion Criteria: * Hypersensitivity to somatostatin or similar peptides * Somatostatin long-acting analog in the past 6 months * Patients who are pregnant or lactating * Patients who are currently incarcerated * Patients with acute infections * Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.) * Patients exceeding the weight limitations of the scanner or are not able to enter the bore of the dPET/CT scanner due to body mass index (BMI)
Updated 2026-02-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.